Level Four Advisory Services LLC lessened its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 5.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 101,137 shares of the company's stock after selling 5,689 shares during the quarter. Level Four Advisory Services LLC's holdings in Docusign were worth $8,233,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the stock. JT Stratford LLC acquired a new position in shares of Docusign in the 1st quarter valued at $847,000. BI Asset Management Fondsmaeglerselskab A S raised its stake in shares of Docusign by 234.7% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 69,203 shares of the company's stock valued at $5,633,000 after acquiring an additional 48,524 shares during the period. Hsbc Holdings PLC raised its stake in shares of Docusign by 55.5% in the 1st quarter. Hsbc Holdings PLC now owns 496,814 shares of the company's stock valued at $40,438,000 after acquiring an additional 177,413 shares during the period. Wellington Management Group LLP raised its stake in shares of Docusign by 372.5% in the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after acquiring an additional 1,440,269 shares during the period. Finally, Korea Investment CORP raised its stake in shares of Docusign by 1.5% in the 1st quarter. Korea Investment CORP now owns 226,985 shares of the company's stock valued at $18,477,000 after acquiring an additional 3,394 shares during the period. Institutional investors and hedge funds own 77.64% of the company's stock.
Analysts Set New Price Targets
DOCU has been the topic of a number of research reports. Wells Fargo & Company raised shares of Docusign from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $67.00 to $80.00 in a research note on Friday, June 13th. UBS Group cut their target price on shares of Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a research note on Friday, June 6th. Wedbush cut their target price on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research note on Thursday, June 12th. Citigroup cut their target price on shares of Docusign from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, June 9th. Finally, Morgan Stanley cut their target price on shares of Docusign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, June 6th. Four research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $89.77.
View Our Latest Research Report on Docusign
Docusign Price Performance
Docusign stock traded up $4.07 during midday trading on Friday, hitting $74.81. 2,692,758 shares of the stock were exchanged, compared to its average volume of 2,172,880. Docusign Inc. has a 1 year low of $54.31 and a 1 year high of $107.86. The firm has a market cap of $15.12 billion, a P/E ratio of 14.14, a P/E/G ratio of 27.92 and a beta of 1.01. The company has a 50 day moving average price of $75.47 and a two-hundred day moving average price of $80.27.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analyst estimates of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The firm's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the business earned $0.82 EPS. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts predict that Docusign Inc. will post 1.17 EPS for the current year.
Docusign declared that its Board of Directors has authorized a stock buyback program on Thursday, June 5th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to purchase up to 6.6% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.
Insider Activity at Docusign
In other Docusign news, insider Robert Chatwani sold 22,875 shares of the firm's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total transaction of $1,710,821.25. Following the completion of the transaction, the insider directly owned 72,126 shares of the company's stock, valued at $5,394,303.54. This trade represents a 24.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Allan C. Thygesen sold 40,000 shares of the firm's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the transaction, the chief executive officer directly owned 143,983 shares of the company's stock, valued at approximately $11,160,122.33. This represents a 21.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock valued at $5,983,631 in the last 90 days. 1.01% of the stock is currently owned by insiders.
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.